Aerobiotix USA

Aerobiotix is a healthcare technology company specializing in advanced air quality management and disinfection systems designed to reduce airborne contaminants and hospital-acquired infections in medical environments. Founded in 2013 and based in Miamisburg, Ohio, the company manufactures medical-grade air purification and disinfection systems utilizing ultraviolet germicidal irradiation (UVGI), HEPA or ULPA filtration, and non-turbulent ultraclean airflow technology. These systems are engineered for continuous autonomous operation in occupied clinical spaces—particularly operating rooms—without disrupting clinical workflows. Aerobiotix's flagship product, Illuvia Sense, is an FDA-registered Class II medical device that autonomously reduces airborne contaminants including infectious bioaerosols, surgical smoke, and volatile organic compounds while providing real-time environmental monitoring and compliance reporting. Clinical evidence demonstrates 99.9% inactivation of bacteria, viruses, and spores, with peer-reviewed studies showing 72% reduction in airborne bacteria during surgery and demonstrated risk reduction for surgical site infections. The company serves hospital systems and surgical facilities globally and supports alignment with AORN, CDC, and ASHRAE air quality guidelines.